Navneet Singh

Navneet Singh

Medical Oncologist

Тhoracic oncology

Postgraduate Institute of Medical Education and Research

Location India, Chandigarh

Dr. Navneet Singh is a thoracic medical oncologist and Professor of Pulmonology at the Postgraduate Institute of Medical Education and Research, specializing in lung cancer, targeted therapies, and immunotherapy. He is internationally recognized for his contributions to clinical research, guideline development, and multidisciplinary lung cancer care, with a strong focus on improving outcomes in non-small cell lung cancer (NSCLC).

Current Position

  • Professor of Pulmonology and Thoracic Oncology, Postgraduate Institute of Medical Education and Research
  • Faculty-in-Charge, Lung Cancer Clinic, Postgraduate Institute of Medical Education and Research
  • Coordinator and Convenor, Multidisciplinary Thoracic Oncology Group, Postgraduate Institute of Medical Education and Research

Education

  • D.M. in Pulmonary Medicine and Critical Care, Postgraduate Institute of Medical Education and Research
  • M.D. in Internal Medicine, Christian Medical College Ludhiana
  • M.B.B.S., Government Medical College Chandigarh

Clinical & Research Focus

  • Thoracic oncology with emphasis on lung cancer
  • Targeted therapies and immunotherapy in NSCLC
  • Clinical trials and biomarker-driven treatment strategies
  • Multidisciplinary management of lung cancer

Academic Profile

  • Author of 250+ peer-reviewed publications and multiple book chapters
  • Active contributor to international clinical practice guidelines in lung cancer
  • Recognized for research in advanced and metastatic NSCLC

Research Innovation & Programs

Dr. Singh has played a major role in advancing multidisciplinary lung cancer care and research:

  • He leads a multidisciplinary thoracic oncology group integrating multiple specialties for comprehensive cancer care
  • He has contributed to development of international guidelines on biomarker testing, systemic therapy, and management of NSCLC
  • He has served as panel co-chair for ASCO guidelines on stage III and stage IV lung cancer
  • His research focuses on translating targeted therapies and immunotherapy into clinical practice
  • He has been actively involved in international collaborations and lung cancer research initiatives

Leadership & Contributions

  • Fellow of American Society of Clinical Oncology (FASCO), among a select group of oncologists globally
  • Member and leader in International Association for the Study of Lung Cancer committees including staging, education, and publications
  • Member of European Society for Medical Oncology Cancer Medicines Committee
  • Former Chair of ASCO International Development and Education Award (IDEA) Steering Committee
  • Secretary of the Indian Society for Study of Lung Cancer (ISSLC)

Awards & Recognition

  • IASLC Clifton Mountain Lectureship Award (2023)
  • IASLC Lung Cancer Care Team Award (Overall Winner, 2019)
  • ASCO International Development and Education Award (IDEA)
  • Fellowships including FRCP (London), FACP, and American College of Chest Physicians

All information is sourced from publicly available materials.